Navigation Links
Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
Date:4/25/2008

LINTHICUM, Md., April 25 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI) announced today that it will release its first quarter 2008 financial results on May 7, 2008, after the close of the market. The company will also host a conference call in conjunction with its first quarter 2008 earnings release the following morning, May 8, 2008 at 10:00 AM EDT.

Those interested in participating in the May 8, 2008 conference call may dial in at 1-800-260-6066 using pass code 7002477, or through simulcast on the internet at http://www.investorcalendar.com/IC/CEPage.asp?ID=128467 . Participants may be asked to provide the title of the conference call, which is "Dialysis Corporation of America 1st Quarter Earnings." The conference call will be available for replay on the company's website http://www.dialysiscorporation.com for a period of thirty days following the call.

Dialysis Corporation of America currently owns 35 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina providing patients with a full range of quality in-center and at-home hemodialysis services, as well as providing in-hospital services in many of the company's markets.

This release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to delays beyond the company's control with respect to future business events, regulation of dialysis operations, determination of reimburs
'/>"/>

SOURCE Dialysis Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
2. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
3. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
4. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
5. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
6. LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern
7. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
8. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
9. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
10. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
11. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (PRWEB) May 17, 2013 •    First of ... Certified for sustainability ,     New facility will help ... , Syngenta unveiled its new crop ... the company’s RTP Innovation Center. The first of its ... to simulate any agricultural climate and precisely measure plant ...
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... Calif. , May 17, 2013 /PRNewswire-iReach/ -- ... has been reached with Switzerland ... of anti-infective human monoclonal antibody (mAb) products, and ... human mAb products for treatment of infections by ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says skin ... known to react more aggressively when hormones change, and acne ... other acne causing factors like P.acnes bacteria and excess dirt ... unsightly acne scars. Adult acne treatment, Probiotic Action shares new ... to reduce and prevent acne scarring. , In order to ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... May 12 An audit of the,state stem ... Proposition 71 that created the agency, Consumer Watchdog ... Controller John Chiang found that with a,relatively minor ... with the requirements of Proposition 71, the,initiative that ...
... 12 MGT Capital Investments,Inc. (AMEX: MGT ... Healthcare,Information Technology ("HCIT") sector, today reported financial results,for ... provided an update on,strategic milestones., Tim Paterson-Brown, ... be a significant turning point for our subsidiaries, ...
... (Nasdaq: IDIX ) announced today that Idenix management,will ... 5th Annual Global,Healthcare Conference on Tuesday, May 20, 2008 ... in Monte Carlo, Monaco., The live and archived ... of Events" in the Idenix Investor Center at, http://www.idenix.com ...
Cached Biology Technology:Controller's Stem Cell Agency Audit Ignores California Agency's Built-in Flaws 2Controller's Stem Cell Agency Audit Ignores California Agency's Built-in Flaws 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4
(Date:5/17/2013)... the interaction of a group of proteins in the ... identified a new target that could increase cell survival. ... School of Biochemistry and published in the EMBO ... eventually lead to new therapies for stroke and other ... by the team which identified a protein, known as ...
(Date:5/17/2013)... Federation of American Societies for Experimental Biology (FASEB) released ... Health (NIH) funding trends highlighting the devastating impact of ... The FASEB analysis follows a May 15th Senate Appropriations ... who testified that the $1.6 billion cut the agency ... a substantial impact on the scientific community." , ...
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2
... -- Pediatric neuroscientists at Oregon Health & Science University ... magnetic field strength MRI to reveal tiny white matter ... MRI. Early, accurate identification of these lesions ... therapy and enable physicians to inform families sooner of ...
... HEIDELBERG -- EMBO today acknowledges the work of ... to join the Young Investigator Programme. These scientists ... group leaders. "The EMBO Young Investigators have ... Gerlind Wallon, EMBO Deputy Director and manager of the ...
... aims to understand the cell and how it organizes ... LMU biophysicist Professor Erwin Frey, who is also a ... (NIM) is working with his group on one particular ... statistical and biological physics and his team, Louis Reese ...
Cached Biology News:First use of high-field MRI in developing brain reveals previously undetectable injuries 222 young researchers join the 2011 EMBO Young Investigator Program 2Attention! End of traffic jam! 2
Human Jagged 2 Biotinylated Affinity Purified PAb...
Griess Reagent component for determination of nitrite in aqueous solutions....
... The SYBR Safe photographic filter ... Gels and Blots) is ideal for ... the SYBR Safe DNA gel stain, ... that the SYBR Safe photographic filter ...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
Biology Products: